E

Efficace

BE1012.858.954

About Efficace

Efficace is a private limited company (BV/SRL) based in Zulte, founded in 2024. Its main activity is classified as "Sanitaire werkzaamheden". For the 2026 financial year, Efficace reported a profit of €33,205. Revenue was not published, which is common for abbreviated accounts. The gross margin came to €52,212. Equity stands at €37,205, a solvency ratio of 46%.

Juridical situation
Normal situation
Company number
1012.858.954
Founding date
Founded on 27-08-2024
EUID number
BEKBOBCE.1012.858.954
Type of enterprise
Rechtspersoon
Location
Staatsbaan 68/A Zulte 9870
Juridical form
BV — Private limited company (BV/SRL)
Activities
43221 - Sanitaire werkzaamheden
Signals
Profitable
Low risk
Good liquidity
Positive cashflow
Positive EBITDA

Financial ratios

Profit
€ 33K
Equity
€ 37K
Gross margin
€ 52K
Health
Solvability > 25%
45.7%
Liquidity > 1.0
2.63
Profitability > 0%
89.3%
2026
Gross margin
€ 52K
EBITDA
€ 50K
Profit
€ 33K
Equity
€ 37K
Solvability
45.68%
Debt
€ 44K
Cash
€ 19K

Frequently asked questions

Answers to the most common questions about Efficace, based on official government data and the filed annual accounts.

What is the VAT number of Efficace?

The VAT number of Efficace is BE1012.858.954.

When was Efficace established?

Efficace was founded in 27-08-2024.

What is the official address of Efficace?

The official address of Efficace is Staatsbaan 68/A Zulte 9870.

What is the legal form of Efficace?

The juridical form of Efficace is Private limited company (BV/SRL).

What is the annual revenue of Efficace?

The 2026 accounts of Efficace do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.

Is Efficace a reliable company?

Efficace is a registered Rechtspersoon with company number 1012.858.954 and can be verified through the official CBE database.

What is the credit limit of Efficace?

The estimated credit limit of Efficace is €54,468.

Is Efficace still active?

Efficace currently has the status "Normal situation" and is active.

Further reading

View all insights

Sources